Outset Medical Inc (NAS:OM)
$ 3.87 -0.12 (-3.01%) Market Cap: 200.17 Mil Enterprise Value: 175.76 Mil PE Ratio: 0 PB Ratio: 2.15 GF Score: 62/100

Outset Medical Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 06:55PM GMT
Release Date Price: $13.27 (-3.70%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us this afternoon. I'm Drew Ranieri, one of the medical device analysts here. It's my pleasure today to have Outset Medical with us. And from the company, we have CEO, Leslie Trigg, and CFO, Nabeel Ahmed.

Before we get started, quick disclosure, but for important disclosures, please see the Morgan Stanley research disclosure website. If you have any questions, please reach out to your sales rep.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

With that, let's kind of dig in here. To start maybe on the GLP-1 kind of debate, it's been kind of an inbound that we've been getting more frequently in med tech and even more so in dialysis. So there's a building view out there that kidney failure and dialysis could even be disrupted from some of the derivative effects of GLP-1s. But it would be great to kind of hear the house view from Outset on how you're thinking about maybe potential

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot